Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Erweiterte Suche bearbeiten
Filter bei nächster Suche beibehalten
collection:"CTG"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?join=AND&bool0%5B%5D=AND&lookfor0%5B%5D=%22Prednisone%22&type0%5B%5D=Subject&op0%5B%5D=OR&filter%5B%5D=collection%3ACTG
/vufind/Search/Results?join=AND&bool0%5B%5D=AND&lookfor0%5B%5D=%22Prednisone%22&type0%5B%5D=Subject&op0%5B%5D=OR&filter%5B%5D=collection%3ACTG
Search /vufind/Search2/Results?join=AND&bool0%5B%5D=AND&lookfor0%5B%5D=%22Prednisone%22&type0%5B%5D=Subject&op0%5B%5D=OR&filter%5B%5D=collection%3ACTG
PubPharm (39)
1
STEPS study : Steroid Treatment Effect in Pulmonary Sarcoidosis
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
2
STEPS study : Steroid Treatment Effect in Pulmonary Sarcoidosis
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
3
An international study to evaluate the effectiveness of Talazoparib in men with a genomic defect and metastatic castration-resistant prostate cancer who received previous chemotherapy and progressed on hormonal treatment : TALAPRO 1: A PHASE 2, OPEN LABEL, RESPONSE RATE STUDY OF TALAZOPARIB IN MEN WITH DNA REPAIR DEFECTS AND METASTATIC CASTRATION RESISTANT PROSTATE CANCER WHO PREVIOUSLY RECEIVED TAXANE BASED CHEMOTHERAPY AND PROGRESSED ON AT LEAST 1 NOVEL HORMONAL AGENT (ENZALUTAMIDE AND/OR ABIRATERONE ACETATE/PREDNISONE)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
4
An international study to evaluate the effectiveness of Talazoparib in men with a genomic defect and metastatic castration-resistant prostate cancer who received previous chemotherapy and progressed on hormonal treatment : TALAPRO 1: A PHASE 2, OPEN LABEL, RESPONSE RATE STUDY OF TALAZOPARIB IN MEN WITH DNA REPAIR DEFECTS AND METASTATIC CASTRATION RESISTANT PROSTATE CANCER WHO PREVIOUSLY RECEIVED TAXANE BASED CHEMOTHERAPY AND PROGRESSED ON AT LEAST 1 NOVEL HORMONAL AGENT (ENZALUTAMIDE AND/OR ABIRATERONE ACETATE/PREDNISONE)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
5
A non-interventional study to assess CYP3A induction by high-dose systemic glucocorticoids and by mitotane using 4ß-hydroxycholesterol as a biomarker : A non-interventional study to assess CYP3A induction by high-dose systemic glucocorticoids and by mitotane using 4ß-hydroxycholesterol as a biomarker - GLUCIND
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
6
A non-interventional study to assess CYP3A induction by high-dose systemic glucocorticoids and by mitotane using 4ß-hydroxycholesterol as a biomarker : A non-interventional study to assess CYP3A induction by high-dose systemic glucocorticoids and by mitotane using 4ß-hydroxycholesterol as a biomarker - GLUCIND
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
7
An international study to evaluate the effectiveness of Talazoparib in men with a genomic defect and metastatic castration-resistant prostate cancer who received previous chemotherapy and progressed on hormonal treatment : TALAPRO 1: A Phase 2, Open-Label, Response Rate Study of Talazoparib in Men With DNA Repair Defects and Metastatic Castration-Resistant Prostate Cancer Who Previously Received Taxane-Based Chemotherapy and Progressed on at Least 1 Novel Hormonal Agent (Enzalutamide and/or Abiraterone Acetate/Prednisone)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
8
An international study to evaluate the effectiveness of Talazoparib in men with a genomic defect and metastatic castration-resistant prostate cancer who received previous chemotherapy and progressed on hormonal treatment : TALAPRO 1: A Phase 2, Open-Label, Response Rate Study of Talazoparib in Men With DNA Repair Defects and Metastatic Castration-Resistant Prostate Cancer Who Previously Received Taxane-Based Chemotherapy and Progressed on at Least 1 Novel Hormonal Agent (Enzalutamide and/or Abiraterone Acetate/Prednisone)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
9
An international study to evaluate the effectiveness of Talazoparib in men with a genomic defect and metastatic castration-resistant prostate cancer who received previous chemotherapy and progressed on hormonal treatment : TALAPRO 1: A PHASE 2, OPEN LABEL, RESPONSE RATE STUDY OF TALAZOPARIB IN MEN WITH DNA REPAIR DEFECTS AND METASTATIC CASTRATION RESISTANT PROSTATE CANCER WHO PREVIOUSLY RECEIVED TAXANE BASED CHEMOTHERAPY AND PROGRESSED ON AT LEAST 1 NOVEL HORMONAL AGENT (ENZALUTAMIDE AND/OR ABIRATERONE ACETATE/PREDNISONE)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
10
An international study to evaluate the effectiveness of Talazoparib in men with a genomic defect and metastatic castration-resistant prostate cancer who received previous chemotherapy and progressed on hormonal treatment : TALAPRO 1: A PHASE 2, OPEN LABEL, RESPONSE RATE STUDY OF TALAZOPARIB IN MEN WITH DNA REPAIR DEFECTS AND METASTATIC CASTRATION RESISTANT PROSTATE CANCER WHO PREVIOUSLY RECEIVED TAXANE BASED CHEMOTHERAPY AND PROGRESSED ON AT LEAST 1 NOVEL HORMONAL AGENT (ENZALUTAMIDE AND/OR ABIRATERONE ACETATE/PREDNISONE)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
1
2
3
4
Nächster »
[4]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Filter aufheben
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Medienart
39
Aufsätze
39
E-Artikel
39
E-Ressourcen
Zeitschriftentitel
36
WHO International Clinical Trials Registry Plat...
3
ClinicalTrials.gov
Thema
39
610
32
Study Type: Interventional
18
Phase: Phase 2
16
Recruitment Status: Authorised-recruitment may ...
15
Recruitment Status: Not yet recruiting
6
Medical Condition: Men With DNA Repair Defects ...
5
Study Type: Observational
4
Medical Condition: Men With DNA Repair Defects ...
4
Medical Condition: Men With DNA Repair Defects ...
4
Recruitment Status: Completed
4
Recruitment Status: Recruiting
2
Medical Condition: A Multicenter Open label Pha...
2
Medical Condition: Any disease, which requires ...
2
Medical Condition: In dieser randomisierten Pha...
2
Medical Condition: In the present study, the co...
2
Medical Condition: Men With DNA Repair Defects ...
2
Medical Condition: Men With DNA Repair Defects ...
2
Medical Condition: Sarcoidosis, sarcoidose, pre...
2
Medical Condition: To assess the clinical effic...
2
Medical Condition: To compare circulating conce...
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
13
2020-
26
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
35
Englisch
2
Deutsch
2
Unbestimmt
Haven't found what you're looking for?
Wird geladen...